永太科技(002326.SZ)第三季度淨利潤預增1500%-1800%
格隆匯9月22日丨永太科技(002326.SZ)公佈,預計2021年前三季度歸屬於上市公司股東的淨利潤35331.64萬元至40169.45萬元,同比增長55.51%-76.81%;其中,第三季度歸屬於上市公司股東的淨利潤25801.69萬元至30639.51萬元,同比增長1500%-1800%。主要來源於公司鋰電材料產品的業績增長。
其中:六氟磷酸鋰產品的市場需求增長顯著,產品價格持續上升,毛利率提高,使得業績同比增長較多;鋰電池添加劑產品 VC 和 FEC 的生產車間在報吿期內建成投產並開始銷售,增加了公司利潤來源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.